ArticleAdvanced healthcare materials2022

In Situ Deployment of Engineered Extracellular Vesicles into the Tumor Niche via Myeloid-Derived Suppressor Cells.

Silvia Duarte-Sanmiguel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.